Concepedia
3
Publications
138
Citations
H-Index
2014
Active since
Affiliations
Dana-Farber Cancer Institute(Current)
Harvard University
Boston Children's Hospital
Children's Hospital of Philadelphia
Royal College of Surgeons in Ireland
Kimberly Bodaar is an author at Dana-Farber Cancer Institute specializing in cell death, medicine, and immunology.
Top concepts
MedicineCell DeathHematologyImmunologyCell BiologyJak-stat Signaling Pathway
Publications per year
2014–2022
PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia
Ingrid M. Ariës, Kimberly Bodaar, Salmaan Karim et al. · The Journal of Experimental Medicine · 2018 · 59 citations · Full text
Repression of BIM mediates survival signaling by MYC and AKT in high-risk T-cell acute lymphoblastic leukemia
Charles H. Reynolds, Justine E. Roderick, James L. LaBelle et al. · Leukemia · 2014 · 58 citations · Full text
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia
Kimberly Bodaar, Natsuko Yamagata, Anais Barthe et al. · Leukemia · 2022 · 21 citations · Full text
Hematological Malignancy, Mixed-phenotype Acute Leukemia, Jak3 Mutations +9
Rows per page
1–3 of 3